MarketLine Blog

Posts about Healthcare

Medical Devices: Strong technological innovation is driving the industry, but it creates new vulnerabilities too

MarketLine

The medical device market is growing well and has been posting consistent and stable revenues for a number of years and some market segments are even achieving double digit growth rates. The market is doing so well because the rate of innovation in new products is allowing treatments that were previously unthinkable; devices that can allow patients to see, walk or hear again for instance. These new types of devices may provide solutions for some of the most unsolvable medical problems over the next decade and this means the health… Read more

Sequencing Quinoa: Food for thought

MarketLine

The pharmaceutical industry has been growing at a strong rate in recent years. One aspect of this market is that of the food supplement. The growing trend especially amongst the older populace and with the hectic lifestyles that are led in developed countries lends support to the supplement industry. The ability of scientists to understand the functions of different genes have assisted in the growth of specific markets and also in the changes to specific plant species. When looking at some of the historic plant species and how they have… Read more

Global healthcare expenditure to hit $9.17 trillion by 2020 as US market burgeons, says MarketLine

MarketLine

Global healthcare expenditure is set to grow from just over $7.2 trillion in 2015 to around $9.17 trillion by 2020, registering a compound annual growth rate (CAGR) of 5%, according to research firm MarketLine. The company’s report states that growth will primarily be driven by the US, which dominates the global market and accounts for nearly 50% of total expenditure. The country also has a good forecast CAGR of 4.6%, exceeding that of Europe and Asia-Pacific, indicating that its share of the healthcare market will rise by 2020. Kate Moody,… Read more

Brexit and Trump’s disastrous effect on science

MarketLine

2016 has been a rollercoaster of a year with regards to political incidences. With the UK voting in favor of leaving the EU in June 2016 and then a follow up of the US voting for President-elect Donald Trump in November of the same year, this has led to a degree of uncertainty in the scientific field. With funding at the forefront of scientific research and the advancement of scientific breakthroughs, the future has been thrown into turmoil as the individuals working in both countries, the US and the UK,… Read more

Vitamins and minerals sales have witnessed strong growth in recent years

MarketLine

The number of households purchasing vitamins grew in 2014 A survey into dietary supplement use has shown that the number of consumers buying these products has grown consecutively between 2012 and 2014. The survey found that growth was largely driven by male consumers, and that children’s multivitamin sales had experienced decline. TABS Group’s survey looked at 1,000 consumers’ purchases over a number of channels in the previous year ending April or May 2014. It was found that 75% of households purchased vitamins at least once in the year ending April… Read more

Arla’s Lactofree increases its consumer base

MarketLine

With an increase in self diagnosed cases of lactose intolerance; sales of lactose free products are expected to grow at a strong rate between 2012 and 2016, according to findings from Food and Health Innovation Services. Arla’s brand Lactofree specializes in offering complete lactose free products which are not readily available in the market.  The Lactofree brand offering includes milk, butter, cheese, cream, yogurt, ice-cream and many more. According to the UK’s National Health Service (NHS), lactose is a sugar found in milk. It cannot become absorbed by the body… Read more

Pfizer and AstraZeneca: merger of majors cancelled or just postponed?

MarketLine

Pfizer is currently the world’s largest research-based pharmaceutical company, with 2013 revenues (excluding consumer health) of $47.9 billion. Recently, it made a bid for the UK’s AstraZeneca (2013 revenues of $25.7 billion) equivalent to £50 ($78) per share. This valued the company at more than £63 billion ($98 billion). A lot of money, you might think, but AstraZeneca lost no time in rejecting the offer. The same thing happened back in January this year, when the American company valued AstraZeneca at around £59 billion. Its CEO commented of the latest… Read more

Emphasis on food is shifting from nutrition to function

MarketLine

Scientific research has typically focused on the primary role of food as a source of energy and nutrients to build up the body. However, in recent years there has been a shift towards the impact that certain food components can have on human health. There has been a wealth of research to support the idea that diet and lifestyle contribute to health and may play a role in some human diseases. The concept of food being linked to human health is not new and has been reported throughout history. During… Read more

Will biosimilar drug Inflectra be Remicade’s nemesis?

MarketLine

On 10 September 2013, Hospira announced that the European Commission had approved its drug Inflectra, a treatment for severe inflammatory conditions such as Crohn’s disease and rheumatoid arthritis. Good news for the company, and of course for patients suffering from these painful and debilitating diseases. Celebrations might be more muted at the headquarters of Johnson & Johnson, however, as Inflectra is essentially a legal copy of its blockbuster drug Remicade. Genuine generic copies of biotech drugs are not feasible, because competitors to the original manufacturer do not have access to… Read more

Serco: A relatively unknown billion pound company

MarketLine

The UK based service company Serco, is a large services business entity that in popular UK media is a relatively low key and unknown business. Despite this the company is one of the key contractors in the UK and is widespread internationally. In 2012 the company turned over £4.9bn (approximately $7.4bn), with net income of £245.3m (approximately $374.2m) which is clear evidence of its scale and scope. Serco has an incredibly diverse business profile, but its key business area is providing governments with private sector contractor options, outsourcing essentially. The… Read more

Pfizer re-entring to the OTC healthcare market

MarketLine

Pfizer Inc., the world’s largest pharmaceutical company, exited the over-the-counter (OTC) healthcare market in 2006 with the sale of its Consumer Healthcare division to Johnson & Johnson. Just 3 years later, in 2009, Pfizer re-entered the market with its acquisition of Wyeth. This article will examine the rise of Pfizer into a diversified healthcare company, the circumstances that led to the disposal of the Consumer Healthcare division, and the subsequent re-entry to the OTC market in 2009. Pfizer, Inc. was originally founded as fine chemicals business. Following a series of… Read more

Coconut Water Consolidating Growth in a Burgeoning Segment

MarketLine

Coconut water has experienced a lot of initial success in the US due to its unique taste profile and sports nutrition benefits. Now is a pivotal time to further consolidate and grow the market, lest it be dismissed as just another ‘fad’ category. The myriad of health benefits associated with consumption means that a natural positioning for coconut water has been a healthier alternative to sports nutrition drinks. This has particular appeal to athletes who have become reticent in recent times to consume some of the more commercially popular sports… Read more

Crest 3D White Using Consumer-Focused Innovation to Form a Point of Differentiation in a Saturated Teeth Whitening Market

MarketLine

An attractive smile – in particular white teeth – has become a sought-after physical attribute among today’s self-expressive and appearance-conscious US consumers. However, with today’s teeth whitening market nearing saturation in Western regions, it has become hard for industry players to achieve standout appeal. This blog entry examines how the Crest and Oral-B brands, which are both owned by Procter & Gamble, have used consumer-focused innovation to form a point of differentiation within the US teeth whitening market. The Crest and Oral-B 3D White Collection achieved $151.1m in first-year sales,… Read more

Preservative Free Packaging helping Beauty Products to tap Consumers

MarketLine

As the attention consumers pay towards natural beauty and cosmetics that are “free-from” ingredients perceived as harmful continues to grow, packaging suppliers including Promens and Aptar have launched sterile packaging solutions that allow cosmetics manufacturers to sell preservative-free products. Although there is no scientific evidence that preservatives such as parabens are actually harmful at the levels at which they are used in personal care products, the combination of media misinformation, lobbying by non-governmental organizations (NGOs), and marketing claims made by the producers of natural products have tainted such chemicals in… Read more

Dettol Targeting the Personal Care Market in the Far East

MarketLine

Reckitt Benckiser reported impressive year-on-year pre-tax profits for 2010, stating that its performance in developing markets had helped offset sluggish activity in its Western markets. As part of this impressive performance, the company said its Dettol brand continued to deliver excellent growth in developing markets. This article examines how the Dettol brand has been well placed to extend its product portfolio into the personal care market in the Far East (particularly China, India, Japan, and South Korea) region of Reckitt Benckiser’s developing market axis, and how competitors can compete with… Read more

Manufacturers in Personal Care Market Adapting to Demands

MarketLine

Unit-dose packs have achieved wide acceptance in categories such as laundry detergents and pharmaceuticals, but progress has been slow in the personal care sector, despite opportunities to add value. This article analyzes the key consumer trends influencing demand for unit-dose packaging within the sector, and examines the extent to which consumer demand for convenience conflicts with concerns over price, performance, and over packaging. This article identifies the key consumer trends that impact upon demand for unit-dose packaging within the personal care sector. It identifies that: Unit-dose packs align well with… Read more

Post Recessionary Opportunities for Calorie Conscious Snacking

MarketLine

The launch of Kraft Foods’ 100 calorie Oreo Thin Crisps in 2004 kick-started the 100 calorie food trend and marked a US snack revolution. However, after five consecutive years of market growth, this snack segment is now dwindling. Perhaps surprisingly, this comes at a time when both weight management and convenience remain core consumer issues. This case study will examine both the consumer and market issues that together will determine the future success of this currently diminishing category. In response to rising obesity levels, enhanced working pressures, and an increasingly… Read more

Remicade, a Biotech Blockbuster in Treating a Variety of Immune System Diseases

MarketLine

Remicade is a drug used in treating a variety of immune system diseases, and its active ingredient is produced through biotechnology.  Johnson & Johnson reported Remicade sales of $4.6 bn in 2010, and the drug is the best-selling “biologic” in the world. This article examines its long journey from an academic research laboratory to a leading position in the pharmaceutical market. In 2010, the world’s best-selling biologic drug was Remicade. Since its original US Food and Drug Administration (FDA) approval as a treatment for Crohn’s disease in 1998, global sales… Read more

McDonald’s: Remaining Relevant in a Health Conscious Society

MarketLine

McDonald’s Corporation is one of the world’s largest food service retailing chains. The company is primarily known for its burgers and fries, which it sells through more than 32,000 restaurants in 117 countries. In 2010, the company served an average of 64 million customers per day. It primarily operates in Europe, Asia Pacific, and the Americas. The company is headquartered in Oak Brook, Illinois and employs about 400,000 people. McDonald’s has been able to successfully increase revenues and profits in recent years in spite of much negative publicity and an… Read more

Sustainable Fashion: A Growing Trend

MarketLine

Sustainable fashion, also known as eco fashion, is part of the larger growing trend of creating more sustainable, environmentally friendly and ethical products. Whilst there is a lack of consensus over definitions, the environmental sourcing and manufacture of materials, reduction of carbon footprint, and safety of consumers and laborers, remain important. Christian Kemp-Griffin, chief mission officer at Edun, an eco-fashion brand that focuses on fair trade for its producers in Africa, says, “Ethical companies make thoughtful decisions and sell product thinking about the people who make the clothes – wages,… Read more

Dexcom Case Study: Launching a Continuous Glucose Monitor

MarketLine

Continuous glucose monitors (CGMs) promise certain diabetics more effective self-management of their condition. Medtronic is a leading US supplier of CGMs, but since 2006 it has faced competition from a small start-up, Dexcom. Management of diabetes often requires electronic blood glucose testing. Until recently, this was done using meters that offered single measurements. Continuous monitors came on to the US market in 2001 and offer certain diabetics the prospect of improved management of their condition, by detecting abnormal glucose levels more rapidly. Medtronic and Dexcom are the only players in… Read more

The OTC Healthcare Market has Become Increasingly Attractive in Recent Years

MarketLine

In recent years, a number of major healthcare companies including Pfizer, Roche, and Bristol-Myers Squibb (BMS) have sold their over-the-counter (OTC) healthcare divisions in a bid to focus their attention on pharmaceuticals. Bayer acquired Roche Consumer Health in 2004, while BMS sold its OTC unit to Novartis in 2005. Pfizer sold its Consumer Healthcare business to Johnson & Johnson in 2006. However, more recently this trend has reversed with companies re-entering the OTC healthcare market. For example, Pfizer marked its re-entry to the market in 2009 with its acquisition of… Read more

Benecol Case Study: A Leader in Cholesterol-Reducing Food

MarketLine

Benecol is a brand licensed by Finnish company, Raisio Group. Branded products include a range of cholesterol-lowering food goods such as fat spreads, yogurts, milk, bread, and soy drinks. Benecol has become one of the market leaders in cholesterol-reducing foods. Benecol was developed after Raisio Group was approached by a Finnish university, which was looking into the use of plant stanols, a class of compounds derived from the phytosterols found in many plants, as a way to combat high cholesterol levels amongst the Finnish population. Benecol margarine was introduced to… Read more

The emerging world of the electronic cigarette market

MarketLine

An electronic cigarette (e-cig) is a new product which replicates the sensation of smoking and delivers to the user a small dose of nicotine that can satiate cravings. This market makes some bold claims as to the health benefits and cost savings to smokers of e-cigs over normal tobacco. The electronic cigarette (e-cig) market has been slowly developing and is starting to gain some traction in some regional markets, with the UK expected to top 1 million users in 2012 By comparison, the UK’s population is estimated to hold around… Read more

Benefits of Research Being Realized – Leads to Sustained Growth for Biotech Market

  The global biotechnology market is experiencing a period of sustained growth as the benefits of research are realized. Many venture capitalists and large pharmaceutical companies are investing in biotechnology in the hope that a new drug, a so-called ‘biotech blockbuster’ will be discovered. Companies and governments alike are also beginning to understand the positive impact on agriculture. Designed agronomic traits can give plants qualities that increase production or reduce the need for other inputs such as chemical pesticides or fertilisers. All of this is creates demand and leads to… Read more

Generics Market – Likely To Continue to produce good growth through to 2016

  The global generics market has produced good growth in recent years and, due to the trend of cheaper generics replacing branded pharmaceutical products when patents end, the market is likely to continue to produce good growth through to 2016. The last few years have seen a number of blockbuster drugs coming to the end of their patents, which has shown the speed with which generics can be introduced and dominate a previously locked up market. This change is happening because the switch to generics from branded drugs is highly… Read more